10.02.2010 • News

Celanese Profit Beats Street; Revenue Up 8%

Celanese posted a better-than-expected fourth-quarter profit as demand for its chemical products increased, pushing revenue higher. The company reported net income of $5 million, or 2 cents per share, compared with a year-earlier loss of $155 million, or $1.09 per share.

Excluding one-time items, including restructuring charges, Celanese posted profit of 50 cents per share. Analysts expected earnings of 47 cents per share, according to Thomson Reuters I/B/E/S. Revenue rose 8 percent to $1.39 billion. Analysts expected $1.25 billion.

Company

Celanese

Brüningstr.
Frankfurt
Germany

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.